10855863

Source:http://linkedlifedata.com/resource/pubmed/id/10855863

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034866, umls-concept:C0040508, umls-concept:C0205464, umls-concept:C0205547, umls-concept:C1524063
pubmed:issue	4
pubmed:dateCreated	2000-6-29
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10855863-10855866
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0375355
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0301-620X
pubmed:author	pubmed-author:AmstutzH CHC, pubmed-author:DoreyF JFJ
pubmed:issnType	Print
pubmed:volume	82
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	473-4
pubmed:dateRevised	2010-11-10
pubmed:meshHeading	pubmed-meshheading:10855863-Arthroplasty, Replacement, Hip, pubmed-meshheading:10855863-Fibrinolytic Agents, pubmed-meshheading:10855863-Humans, pubmed-meshheading:10855863-Postoperative Complications, pubmed-meshheading:10855863-Premedication, pubmed-meshheading:10855863-Survival Rate, pubmed-meshheading:10855863-Thromboembolism, pubmed-meshheading:10855863-Thrombolytic Therapy
pubmed:year	2000
pubmed:articleTitle	Are recommendations for the routine use of pharmacological thromboprophylaxis in total hip arthroplasty justified?
pubmed:affiliation	Joint Replacement Institute, Los Angeles, California 90007, USA.
pubmed:publicationType	Journal Article